TW200634001A - Novel compounds - Google Patents

Novel compounds

Info

Publication number: TW200634001A
Authority: TW; Taiwan
Prior art keywords: novel compounds; diseases; ethyl; substituted; alkyl
Prior art date: 2004-12-15

Application number

TW094144382A

Other languages

English (en)

Inventor

David Waterson

David Jonas Persson

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-15

Filing date

2005-12-15

Publication date

2006-10-01

2005-12-15 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-10-01 Publication of TW200634001A publication Critical patent/TW200634001A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

TW094144382A 2004-12-15 2005-12-15 Novel compounds TW200634001A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0427403.1A GB0427403D0 (en)	2004-12-15	2004-12-15	Novel compounds I

Publications (1)

Publication Number	Publication Date
TW200634001A true TW200634001A (en)	2006-10-01

Family

ID=34090044

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW094144382A TW200634001A (en)	2004-12-15	2005-12-15	Novel compounds

Country Status (29)

Country	Link
US (1)	US8129412B2 (zh)
EP (1)	EP1828166B1 (zh)
JP (1)	JP5042849B2 (zh)
KR (1)	KR20070090921A (zh)
CN (1)	CN101080402B (zh)
AR (1)	AR051797A1 (zh)
AU (1)	AU2005315459B2 (zh)
BR (1)	BRPI0519057A2 (zh)
CA (1)	CA2589525A1 (zh)
CY (1)	CY1109376T1 (zh)
DE (1)	DE602005015617D1 (zh)
DK (1)	DK1828166T3 (zh)
ES (1)	ES2328836T3 (zh)
GB (1)	GB0427403D0 (zh)
HR (1)	HRP20090489T1 (zh)
IL (1)	IL183590A0 (zh)
MX (1)	MX2007006744A (zh)
NO (1)	NO20073550L (zh)
NZ (1)	NZ555684A (zh)
PL (1)	PL1828166T3 (zh)
PT (1)	PT1828166E (zh)
RS (1)	RS51193B (zh)
RU (1)	RU2388758C2 (zh)
SA (1)	SA05260406B1 (zh)
SI (1)	SI1828166T1 (zh)
TW (1)	TW200634001A (zh)
UA (1)	UA89067C2 (zh)
WO (1)	WO2006064218A1 (zh)
ZA (1)	ZA200705068B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE542825T1 (de)	2007-10-19	2012-02-15	Boehringer Ingelheim Int	Substituierte piperidino-dihydrothienopyrimidine
WO2009138777A1 (en) *	2008-05-12	2009-11-19	Astrazeneca Ab	Process for the preparation of alkoxy-phenoxy-pi peridine
US7759512B2 (en)	2008-07-21	2010-07-20	3M Innovative Properties Company	Aqueous methods for making fluorinated sulfonate esters
CN102234287B (zh)	2010-04-26	2015-08-05	上海阳帆医药科技有限公司	硝基咪唑类化合物、其制备方法和用途
US9255074B2 (en)	2010-07-16	2016-02-09	Abbvie Inc.	Process for preparing antiviral compounds
US8975443B2 (en)	2010-07-16	2015-03-10	Abbvie Inc.	Phosphine ligands for catalytic reactions
WO2012009698A1 (en)	2010-07-16	2012-01-19	Abbott Laboratories	Phosphine ligands for catalytic reactions
MX2013000623A (es)	2010-07-16	2013-06-13	Abbvie Inc	Proceso para la preparación de compuestos antivirales.
HUP1300139A2 (en)	2013-03-06	2014-09-29	Richter Gedeon Nyrt	Phenoxypiperidine h3 antagonists
US20160364553A1 (en) *	2015-06-09	2016-12-15	Intel Corporation	System, Apparatus And Method For Providing Protected Content In An Internet Of Things (IOT) Network
GB201610056D0 (en) *	2016-06-09	2016-07-27	Galapagos Nv And Laboratoires Servier Les	Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9919776D0 (en)	1998-08-31	1999-10-27	Zeneca Ltd	Compoujnds
BR0011339A (pt) *	1999-06-04	2002-03-19	Astrazeneca Ab	Composto, uso, e processo para preparar o mesmo, composição farmacêutica, e, método para tratar uma condição de doença mediada por metaloproteinase
WO2001062742A1 (en) *	2000-02-21	2001-08-30	Astrazeneca Ab	Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
SE0100902D0 (sv) *	2001-03-15	2001-03-15	Astrazeneca Ab	Compounds
SE0301922D0 (sv) *	2003-06-27	2003-06-27	Astrazeneca Ab	Novel compounds

2004
- 2004-12-15 GB GBGB0427403.1A patent/GB0427403D0/en not_active Ceased
2005
- 2005-12-14 JP JP2007546173A patent/JP5042849B2/ja not_active Expired - Fee Related
- 2005-12-14 PL PL05818265T patent/PL1828166T3/pl unknown
- 2005-12-14 WO PCT/GB2005/004811 patent/WO2006064218A1/en not_active Ceased
- 2005-12-14 AU AU2005315459A patent/AU2005315459B2/en not_active Ceased
- 2005-12-14 SA SA05260406A patent/SA05260406B1/ar unknown
- 2005-12-14 EP EP05818265A patent/EP1828166B1/en not_active Expired - Lifetime
- 2005-12-14 RU RU2007121222/04A patent/RU2388758C2/ru not_active IP Right Cessation
- 2005-12-14 MX MX2007006744A patent/MX2007006744A/es active IP Right Grant
- 2005-12-14 HR HR20090489T patent/HRP20090489T1/hr unknown
- 2005-12-14 PT PT05818265T patent/PT1828166E/pt unknown
- 2005-12-14 DK DK05818265T patent/DK1828166T3/da active
- 2005-12-14 CN CN2005800432057A patent/CN101080402B/zh not_active Expired - Fee Related
- 2005-12-14 BR BRPI0519057-6A patent/BRPI0519057A2/pt not_active IP Right Cessation
- 2005-12-14 NZ NZ555684A patent/NZ555684A/en not_active IP Right Cessation
- 2005-12-14 DE DE602005015617T patent/DE602005015617D1/de not_active Expired - Lifetime
- 2005-12-14 US US11/793,358 patent/US8129412B2/en not_active Expired - Fee Related
- 2005-12-14 UA UAA200706159A patent/UA89067C2/ru unknown
- 2005-12-14 KR KR1020077013343A patent/KR20070090921A/ko not_active Ceased
- 2005-12-14 RS RSP-2009/0397A patent/RS51193B/sr unknown
- 2005-12-14 CA CA002589525A patent/CA2589525A1/en not_active Abandoned
- 2005-12-14 SI SI200530774T patent/SI1828166T1/sl unknown
- 2005-12-14 ES ES05818265T patent/ES2328836T3/es not_active Expired - Lifetime
- 2005-12-15 TW TW094144382A patent/TW200634001A/zh unknown
- 2005-12-15 AR ARP050105275A patent/AR051797A1/es not_active Application Discontinuation
2007
- 2007-05-31 IL IL183590A patent/IL183590A0/en unknown
- 2007-06-12 ZA ZA200705068A patent/ZA200705068B/xx unknown
- 2007-07-09 NO NO20073550A patent/NO20073550L/no not_active Application Discontinuation
2009
- 2009-09-17 CY CY20091100960T patent/CY1109376T1/el unknown

Also Published As

Publication number	Publication date
SA05260406B1 (ar)	2009-02-02
CY1109376T1 (el)	2014-07-02
NO20073550L (no)	2007-09-11
JP5042849B2 (ja)	2012-10-03
HK1108435A1 (zh)	2008-05-09
DE602005015617D1 (de)	2009-09-03
IL183590A0 (en)	2007-09-20
ZA200705068B (en)	2008-10-29
NZ555684A (en)	2009-11-27
CN101080402A (zh)	2007-11-28
HRP20090489T1 (hr)	2009-10-31
ES2328836T3 (es)	2009-11-18
AU2005315459B2 (en)	2009-01-08
RU2388758C2 (ru)	2010-05-10
BRPI0519057A2 (pt)	2008-12-23
AU2005315459A1 (en)	2006-06-22
RS51193B (sr)	2010-10-31
MX2007006744A (es)	2007-07-09
DK1828166T3 (da)	2009-10-05
EP1828166B1 (en)	2009-07-22
US8129412B2 (en)	2012-03-06
CA2589525A1 (en)	2006-06-22
SI1828166T1 (sl)	2009-12-31
AR051797A1 (es)	2007-02-07
UA89067C2 (ru)	2009-12-25
WO2006064218A1 (en)	2006-06-22
KR20070090921A (ko)	2007-09-06
CN101080402B (zh)	2010-12-08
US20080280950A1 (en)	2008-11-13
PT1828166E (pt)	2009-09-16
JP2008524184A (ja)	2008-07-10
RU2007121222A (ru)	2009-01-27
PL1828166T3 (pl)	2009-12-31
EP1828166A1 (en)	2007-09-05
GB0427403D0 (en)	2005-01-19

Publication	Publication Date	Title
TW200745111A (en)	2007-12-16	New compounds
MXPA04009163A (es)	2004-12-07	Nuevos compuestos.
TW200621762A (en)	2006-07-01	Novel compounds
SE0202462D0 (sv)	2002-08-14	Novel use
MX2009006742A (es)	2009-08-24	Inhibidores acilaminopirazoles como fgfr.
CY1109962T1 (el)	2014-09-10	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
BR0313407A (pt)	2005-07-05	Novo uso de derivados de benzotiazol
CY1109376T1 (el)	2014-07-02	Παραγωγα υδαντοϊνης χρησιμα ως αναστολεις μεταλλοπρωτεϊνασης
NO20065904L (no)	2007-02-20	Terapeutiske forbindelser
WO2005037798A3 (en)	2005-06-16	Amide or thiomide derivatives and their use in the treatment of pain
NO20070837L (no)	2007-04-16	Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
CY1109366T1 (el)	2014-07-02	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
SE0100569D0 (sv)	2001-02-20	New compounds
TW200626553A (en)	2006-08-01	Novel compounds
SE0302546D0 (sv)	2003-09-24	New compounds
TW200639156A (en)	2006-11-16	New compounds
MXPA05010020A (es)	2005-11-17	Derivados de oxamida.
TW200606164A (en)	2006-02-16	New compounds
TW200626581A (en)	2006-08-01	Compounds, compositions containing them, preparation thereof and uses thereof
TW200800984A (en)	2008-01-01	New compounds
SE0102057D0 (sv)	2001-06-08	New Salts I
MY139613A (en)	2009-10-30	Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
TW200640465A (en)	2006-12-01	New pharmaceutically active compounds for the treatment of respiratory diseases
TW200728291A (en)	2007-08-01	Amide derivatives
SE0102058D0 (sv)	2001-06-08	New Salts II